The Age-Related Eye Disease Study 2 (AREDS2) Research Group conducted a multicenter, double-masked clinical trial to determine whether daily oral supplementation with lutein/zeaxanthin affects the risk for cataract surgery.
This randomized clinical trial evaluates the potential efficacy and assesses the safety of orally administered valproic acid in the treatment of autosomal dominant retinitis pigmentosa.
This cross-sectional study aims to determine the genetic penetrance of macular telangiectasia type 2 (MacTel) in parents and siblings of affected families.
This case report describes a 67-year-old woman with a fully expressed form of choroideremia due to coexistent Turner syndrome.
This case report describes crystalline maculopathy associated with high-dose lutein supplementation.
This randomized trial reports that among older individuals with age-related macular degeneration supplements containing long-chain fatty acids and/or lutein and zeaxanthin had no effect on cognitive function.
This randomized trial reports point-of-use mixing and administration of 2 doses of H7N9 vaccine at the lowest tested antigen dose with MF59 adjuvant, producing seroconversion in participants.
Flanders and coauthors examine the association between pharmacologic venous thromboembolism prophylaxis rates and hospital-associated venous thromboembolism.
You currently have no searches saved.
Create a personal account or sign in to: